{"id":"W2138602439","doi":"10.1200/jco.2003.08.137","title":"Risk of Acute Leukemia Following Epirubicin-Based Adjuvant Chemotherapy: A Report From the National Cancer Institute of Canada Clinical Trials Group","year":2003,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":91,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Epirubicin; Medicine; Cyclophosphamide; Internal medicine; Breast cancer; Chemotherapy; Oncology; Cancer; Leukemia; Fluorouracil; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02186673,0.0004071459,0.001061725,0.0005990894,0.0006707116,0.001141584,0.0007518378,0.0007814681,0.001064315],"category_scores_gemma":[0.05060557,0.0002966345,0.001474417,0.001415889,0.000727532,0.000281631,0.0004930113,0.001480473,0.00009427939],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005830486,"about_ca_system_score_gemma":0.008621024,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1806202,"about_ca_topic_score_gemma":0.2946224,"domain_scores_codex":[0.9850072,0.008615663,0.001109862,0.0008065164,0.004074578,0.0003861578],"domain_scores_gemma":[0.9475441,0.02575963,0.01566559,0.001733832,0.007642362,0.00165443],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04309214,0.0001409474,0.8282522,0.003138684,0.01229016,0.0002375635,0.0002518309,0.002876185,0.0006039501,0.0005974543,0.007976226,0.1005426],"study_design_scores_gemma":[0.007893176,0.003496677,0.9448879,0.00102292,0.01901715,0.0009314489,0.0001125823,0.005298399,0.001236927,0.0004875486,0.01553887,0.00007656109],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.841625,0.122177,0.004808245,0.007931426,0.0003106062,0.002230188,0.01066844,0.0000937173,0.01015524],"genre_scores_gemma":[0.9766913,0.01592189,0.001396696,0.00125808,0.0002286761,0.0003839381,0.002773475,0.00001718598,0.001328717],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1806202,"threshold_uncertainty_score":0.3591377,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1163945546688702,"score_gpt":0.4745238978335926,"score_spread":0.3581293431647224,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}